ABBV vs BIIB: Options Risk Comparison

AbbVie Inc. and BIOGEN INC. compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

Metric	ABBV	BIIB
Risk Score	100	71
Risk Band	HIGH	HIGH
IV Rank	75.7	86.7
IV %	32.9%	48.2%
Edge Score	-24	+16
Price Δ	-2.2%	-0.7%
Next Earnings	2026-10-30	2026-10-28
Sector	Health Care	Health Care

Which has higher options risk?

AbbVie Inc. (ABBV) currently carries the higher options risk score (100 vs 71 for BIIB) — meaning more active catalysts that can drive an overnight move. For selling option premium, BIOGEN INC. (BIIB) has the better edge score (+16) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan ABBV → Scan BIIB →

Full risk pages

ABBV risk, IV & earnings BIIB risk, IV & earnings

More Health Care comparisons

ABBV vs ABT ABBV vs A ABBV vs ALGN ABBV vs AMGN ABBV vs BAX ABBV vs BDX ABBV vs TECH ABBV vs BSX

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer